MW4881A1 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
MW4881A1
MW4881A1 MW48/81A MW4881A MW4881A1 MW 4881 A1 MW4881 A1 MW 4881A1 MW 48/81 A MW48/81 A MW 48/81A MW 4881 A MW4881 A MW 4881A MW 4881 A1 MW4881 A1 MW 4881A1
Authority
MW
MALAWI
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
MW48/81A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of MW4881A1 publication Critical patent/MW4881A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194Radicals derived from thio- or thiono carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MW48/81A 1980-11-14 1981-11-04 Heterocyclic compounds MW4881A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036680 1980-11-14

Publications (1)

Publication Number Publication Date
MW4881A1 true MW4881A1 (en) 1983-09-14

Family

ID=10517317

Family Applications (1)

Application Number Title Priority Date Filing Date
MW48/81A MW4881A1 (en) 1980-11-14 1981-11-04 Heterocyclic compounds

Country Status (20)

Country Link
US (4) US4423045A (ru)
EP (1) EP0052442B1 (ru)
JP (3) JPS57109771A (ru)
KR (1) KR830007624A (ru)
AU (1) AU7709181A (ru)
CA (1) CA1176250A (ru)
DD (1) DD202020A5 (ru)
DE (1) DE3172252D1 (ru)
DK (1) DK498881A (ru)
ES (2) ES507126A0 (ru)
FI (1) FI813566L (ru)
GR (1) GR79554B (ru)
HU (1) HU185979B (ru)
MW (1) MW4881A1 (ru)
NO (1) NO813850L (ru)
NZ (1) NZ198967A (ru)
PL (2) PL233809A1 (ru)
PT (1) PT73995B (ru)
ZA (1) ZA817597B (ru)
ZW (1) ZW26381A1 (ru)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
ZA827641B (en) * 1981-11-12 1983-09-28 Ici Plc Thiadiazine, oxadiazine and triazine derivatives which possess cardiotonic and/or antihypertensive activity
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
JPS5962578A (ja) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc オキサジアジン誘導体およびそれを含有する医薬組成物
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
JPS59196874A (ja) * 1983-04-22 1984-11-08 Fujisawa Pharmaceut Co Ltd トリアジン誘導体
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8329784D0 (en) * 1983-11-08 1983-12-14 Smith Kline French Lab Heterocyclic compounds
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
WO1986002074A1 (en) 1984-10-04 1986-04-10 Zenyaku Kogyo Kabushiki Kaisha Novel 1,4-thiazine derivatives, process for their preparation, and cardiotonics containing the same
JPS61106574A (ja) * 1984-10-29 1986-05-24 Yoshitomi Pharmaceut Ind Ltd オキサ(またはチア)ジアジン誘導体
DE3531658A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
FR2592878B1 (fr) * 1986-01-16 1988-12-16 Pf Medicament Monoaryl-5 as triazinones-3 substituees en position 2, leur procede de preparation et leur application en tant que medicaments
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
US4861773A (en) * 1986-04-28 1989-08-29 Smith Kline & French Laboratories Limited Heterocyclic compounds
GB8610369D0 (en) * 1986-04-28 1986-06-04 Smith Kline French Lab Heterocyclic compounds
DE3706427A1 (de) * 1987-02-27 1988-09-08 Boehringer Mannheim Gmbh Neue substituierte 3h-indole, zwischenprodukte, verfahren zu ihrer herstellung sowie arzneimittel
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
TW309520B (ru) * 1994-04-26 1997-07-01 Mitsubishi Chem Corp
CN1113875C (zh) 1994-05-04 2003-07-09 拜尔公司 取代的芳族硫代羧酰胺及其作为除草剂的用途
USRE39263E1 (en) * 1994-05-04 2006-09-05 Bayer Aktiengesellschaft Substituted aromatic thiocarboxylic acid amides and their use as herbicides
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
DE19929781A1 (de) * 1999-06-29 2001-01-04 Bayer Ag N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
BRPI0618609A2 (pt) 2005-11-16 2011-09-06 Novartis Ag biomarcadores para tratamento com anticorpo anti-nogo-a em danos à medula espinhal
EP2530073A4 (en) 2010-01-27 2014-10-08 Mitsubishi Rayon Co NEW CHAIN TRANSFER AND EMULSION POLYMERIZATION THEREWITH
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
WO2020157194A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft 1,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314455A (en) * 1964-07-24 1967-04-18 Black Clawson Co Band saw resawing machine
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
FR8169M (ru) * 1967-05-17 1970-08-31
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4097425A (en) * 1975-08-28 1978-06-27 General Electric Company Thermoplastic formable blends, a foaming method and products made thereby
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
ZA827641B (en) * 1981-11-12 1983-09-28 Ici Plc Thiadiazine, oxadiazine and triazine derivatives which possess cardiotonic and/or antihypertensive activity
US4489074A (en) * 1982-11-12 1984-12-18 Imperial Chemical Industries, Plc 1,3,4-Thiadiazin-2-ones
JPH072947B2 (ja) * 1985-06-27 1995-01-18 松下電子工業株式会社 螢光体

Also Published As

Publication number Publication date
DK498881A (da) 1982-05-15
AU7709181A (en) 1982-05-20
PL238802A1 (en) 1983-09-12
DE3172252D1 (en) 1985-10-17
HU185979B (en) 1985-04-28
ES8307231A1 (es) 1983-07-01
ES507126A0 (es) 1983-07-01
ZW26381A1 (en) 1983-06-01
FI813566L (fi) 1982-05-15
US4423045A (en) 1983-12-27
US4683232A (en) 1987-07-28
JPS57109771A (en) 1982-07-08
ES8401044A1 (es) 1983-11-16
US4503054A (en) 1985-03-05
JPS6230771A (ja) 1987-02-09
NZ198967A (en) 1984-12-14
CA1176250A (en) 1984-10-16
EP0052442A1 (en) 1982-05-26
NO813850L (no) 1982-05-18
US4587246A (en) 1986-05-06
ZA817597B (en) 1982-10-27
GR79554B (ru) 1984-10-30
PT73995B (en) 1983-06-20
DD202020A5 (de) 1983-08-24
KR830007624A (ko) 1983-11-04
ES516588A0 (es) 1983-11-16
JPS6236370A (ja) 1987-02-17
EP0052442B1 (en) 1985-09-11
PL233809A1 (en) 1983-09-12
PT73995A (en) 1981-12-01
JPH0572384B2 (ru) 1993-10-12

Similar Documents

Publication Publication Date Title
GB2078719B (en) Heterocyclic compounds
DE3172252D1 (en) Heterocyclic compounds
ZW19381A1 (en) Heterocyclic compounds
JPS56154464A (en) Heterocyclic compound
GB2119801B (en) Heterocyclic compounds
ZA815541B (en) Heterocyclic compounds
GB8315564D0 (en) Heterocyclic compounds
ZA815540B (en) Heterocyclic compounds
JPS56139484A (en) Heterocyclic compound
JPS5791986A (en) Heterocyclic compounds
ZA828304B (en) Heterocyclic compounds
GB2083463B (en) Heterocyclic compounds
GB8300095D0 (en) Heterocyclic compounds
PT76791A (en) Heterocyclic compounds
GB2083476B (en) Heterocyclic compounds
GB2082175B (en) Heterocyclic compounds
IL67098A0 (en) Heterocyclic compounds
ZA813354B (en) Heterocyclic compounds
DE3377060D1 (en) Heterocyclic compounds
ZA818703B (en) Heterocyclic compounds
GB8325760D0 (en) Heterocyclic compounds
ZA834032B (en) Heterocyclic compounds
GB8304744D0 (en) Heterocyclic compounds
GB8308866D0 (en) Heterocyclic compounds
ZA831466B (en) Heterocyclic compounds